QUETIAPINE XR recall in Canada: May exceed acceptable intake limit
In plain language
This recall involves QUETIAPINE XR tablets sold in Canada. It's being recalled because affected lots may exceed the acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP). Consult your healthcare provider before stopping use and follow the return/repair steps in the official notice.
What to do
- Consult your healthcare provider prior to discontinuing use.
- Verify if your product is affected.
- Contact the recalling firm if you have questions.
- Report any health product related side effects to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
QUETIAPINE XR/50MG
Lot: M2213000, M2213001, M2215146, M2214004, M2214005
QUETIAPINE XR/150MG
Lot: M2214685, M2214686, M2214687
QUETIAPINE XR/200MG
Lot: M2214012, M2214013, M2214014
QUETIAPINE XR/300MG
Lot: M2214016, M2214017, M2214018
QUETIAPINE XR/400MG
Lot: M2214020
Why this matters
May exceed acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP)
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: M2213000, M2213001, M2215146, M2214004, M2214005, M2214012, M2214013, M2214014, M2214016, M2214017, M2214018, M2214020, M2214685, M2214686, M2214687
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
May exceed acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP)
What should consumers do?
Consult your healthcare provider prior to discontinuing use. Verify if your product is affected. Contact the recalling firm if you have questions. Report any health product related side effects to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. May exceed acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP)
When was this product recalled?
This product was recalled on January 7, 2025.
Is the QUETIAPINE XR brand affected by this recall?
Yes, QUETIAPINE XR products are affected by this recall. This recall involves QUETIAPINE XR tablets sold in Canada. It's being recalled because affected lots may exceed the acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP). Consult your healthcare provider before stopping use and follow the return/repair steps in the official notice.